A method of providing relatively long term diminishment or prevention of painful disorders comprises the topical or intranasal administration of civamide or one of its salts in an amount of about 0.001% to 1.0% by weight in a pharmaceutically acceptable vehicle over a relatively short term treatment period to provide unexpectedly long-lasting pain relief.

 
Web www.patentalert.com

> Flagellin gene, flaC of Campylobacter

~ 00364